Diagnostic options · UAE

Genetics tests in Dubai & UAE

Compare available Genetics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

2,789

Listed price range

-1.00–50,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Genetics test prices

Showing 331–345 of 2,789 matching tests.

Genetics diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4254 CACNA1B (DYT23) Gene NGS Test This test analyzes the CACNA1B gene for pathogenic variants associated with DYT23, an early-onset isolated dystonia.	Peripheral Whole Blood	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1B gene", "Single nucleotide variants", "Insertions/Deletions (Indels)", "Copy Number Variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications"] Indications ["Suspected DYT23 dystonia", "Early-onset isolated dystonia", "Family history of dystonia"] Measurement technique Confirm with laboratory Codes LOINC: 94705-0 ICD-10: G24.1 Clinical summary This test analyzes the CACNA1B gene for pathogenic variants associated with DYT23, an early-onset isolated dystonia.
TEST-4409 CACNA1C Gene Brugada Syndrome Type 3 Genetic Test This test identifies pathogenic variants in the CACNA1C gene associated with Brugada syndrome type 3.	Peripheral Whole Blood (EDTA tube)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1C gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)", "Splice-site variants"] Parameters [] Preparation ["No fasting required", "No medication adjustments required", "Bring valid Emirates ID", "Complete consent form", "Provide brief clinical history questionnaire", "Inform phlebotomist if taking anticoagulants"] Indications ["Diagnosis of Brugada syndrome type 3", "Risk stratification for sudden cardiac death", "Cascade screening of family members", "Evaluation of unexplained syncope or sudden cardiac death in family history"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: I49.8 Clinical summary This test identifies pathogenic variants in the CACNA1C gene associated with Brugada syndrome type 3.
TEST-4171 CACNA1C Gene Long QT Syndrome Type 8 Genetic Test This test evaluates the CACNA1C gene for pathogenic variants associated with Long QT Syndrome Type 8 (Timothy syndrome).	Whole blood (EDTA), buccal swab, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1C gene", "Coding region and flanking intronic regions of the CACNA1C gene"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Personal or family history of unexplained sudden cardiac arrest, syncope, or prolonged QT interval on ECG", "Asymptomatic relatives of a confirmed Timothy syndrome patient", "Competitive athletes undergoing pre-participation cardiac screening", "Families planning pregnancy when one partner carries a known CACNA1C variant"] Measurement technique Confirm with laboratory Codes LOINC: 77991-4 ICD-10: I45.81 Clinical summary This test evaluates the CACNA1C gene for pathogenic variants associated with Long QT Syndrome Type 8 (Timothy syndrome).
TEST-4106 CACNA1D Gene Sequencing Test (Sinoatrial Node Dysfunction & Deafness) This test evaluates the CACNA1D gene for pathogenic variants associated with sinoatrial node dysfunction and deafness (SANDD). It identifies genetic mutations linked to specific ca...	Peripheral whole blood (EDTA) or dried blood spot (FTA card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1D gene", "Single nucleotide variants", "Small insertions/deletions", "Deep intronic mutations"] Parameters [] Preparation ["Do not discontinue prescribed cardiac medications or hearing loss therapies without consulting your physician."] Indications ["Patients with unexplained slow heart rate", "Patients with sick sinus syndrome", "Patients with progressive sensorineural hearing loss", "Suspected hereditary basis for cardiac or hearing conditions"] Measurement technique Confirm with laboratory Codes LOINC: 82939-0 ICD-10: I49.5, H90.3 Clinical summary This test evaluates the CACNA1D gene for pathogenic variants associated with sinoatrial node dysfunction and deafness (SANDD). It identifies genetic mutations linked to specific cardiac and hearing conditions.
TEST-5526 CACNA1D Gene Sinoatrial Node Dysfunction and Deafness Genetic Test This genetic test identifies pathogenic variants in the CACNA1D gene associated with hereditary sinoatrial node dysfunction and sensorineural hearing loss.	Peripheral whole blood or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1D gene", "Presence of mutations causing sinoatrial node dysfunction and deafness"] Parameters [] Preparation ["No specific fasting required.", "Inform your doctor about all medications you are taking."] Indications ["Diagnosis of hereditary sinoatrial node dysfunction", "Diagnosis of hereditary bilateral sensorineural hearing loss", "Family screening for CACNA1D-related conditions"] Measurement technique Confirm with laboratory Codes LOINC: 83018-4 ICD-10: I45.5, H90.5 Clinical summary This genetic test identifies pathogenic variants in the CACNA1D gene associated with hereditary sinoatrial node dysfunction and sensorineural hearing loss.
TEST-3462 CACNA1F Gene Aland Island Eye Disease Genetic Test This test evaluates the CACNA1F gene for variants causing Aland Island eye disease (AIED), an X-linked congenital stationary night blindness.	Peripheral Whole Blood (EDTA), Dried Blood Spot (FTA card), or Extracted Genomic DNA	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1F gene", "Copy Number Variants (CNVs) in CACNA1F exons"] Parameters [] Preparation ["No fasting or special preparation is needed."] Indications ["Diagnosis of Aland Island eye disease (AIED)", "Family history of AIED", "Carrier screening for AIED", "Differential diagnosis of night blindness"] Measurement technique Confirm with laboratory Codes LOINC: 81247-7 ICD-10: H53.63 Clinical summary This test evaluates the CACNA1F gene for variants causing Aland Island eye disease (AIED), an X-linked congenital stationary night blindness.
TEST-3611 CACNA1F Gene Cone-Rod Dystrophy, X-Linked Type 3 Genetic Test This genetic test analyzes the CACNA1F gene for mutations associated with X-linked cone-rod dystrophy.	Peripheral Whole Blood (EDTA Tube)	3 to 4 Weeks (21 – 28 Business Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic mutations in the CACNA1F gene", "Single-nucleotide variants", "Small insertions/deletions", "Copy Number Variations (CNV)"] Parameters [] Preparation ["No specific fasting required.", "Inform the lab of any medications being taken."] Indications ["Suspected diagnosis of X-linked cone-rod dystrophy", "Family history of cone-rod dystrophy", "Need for genetic counseling and recurrence risk assessment", "Eligibility assessment for gene therapy clinical trials"] Measurement technique Confirm with laboratory Codes LOINC: 94233-3 ICD-10: H35.54 Clinical summary This genetic test analyzes the CACNA1F gene for mutations associated with X-linked cone-rod dystrophy.
TEST-4546 CACNA1S Gene Hypokalemic Periodic Paralysis Type 1 Genetic Test This genetic test identifies pathogenic variants in the CACNA1S gene, confirming the diagnosis of hypokalemic periodic paralysis type 1.	Whole blood (EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 weeks (21–28 calendar days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNA1S gene"] Parameters [] Preparation ["No specific fasting required", "Avoid strenuous exercise immediately before sample collection"] Indications ["Suspected diagnosis of hypokalemic periodic paralysis type 1", "Family history of hypokalemic periodic paralysis type 1", "Differential diagnosis of episodic weakness"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G72.3 Clinical summary This genetic test identifies pathogenic variants in the CACNA1S gene, confirming the diagnosis of hypokalemic periodic paralysis type 1.
TEST-4386 CACNB2 Gene Brugada Syndrome Type 4 Genetic Test This test identifies mutations in the CACNB2 gene associated with Brugada syndrome type 4, a condition predisposing to sudden cardiac arrest.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CACNB2 gene variants", "Pathogenic mutations"] Parameters [] Preparation [] Indications ["Diagnosis of Brugada syndrome type 4", "Risk stratification for sudden cardiac death", "Cascade family screening"] Measurement technique Confirm with laboratory Codes LOINC: 48807-7 ICD-10: I49.8 Clinical summary This test identifies mutations in the CACNB2 gene associated with Brugada syndrome type 4, a condition predisposing to sudden cardiac arrest.
TEST-4456 CACNB4 Gene Episodic Ataxia Type 5 (EA5) Genetic Test This genetic test analyzes the CACNB4 gene for pathogenic variants associated with Episodic Ataxia Type 5 (EA5). It helps confirm the genetic cause of the disorder in symptomatic i...	Whole Blood (EDTA tube), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the CACNB4 gene", "Coding region and splice sites of the CACNB4 gene"] Parameters [] Preparation ["Maintain normal activities", "Stay hydrated", "Do not stop any medications unless advised by your doctor"] Indications ["Suspected diagnosis of Episodic Ataxia Type 5 (EA5)", "Family history of EA5", "Genetic counseling and family risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21760-0 ICD-10: G11.1 Clinical summary This genetic test analyzes the CACNB4 gene for pathogenic variants associated with Episodic Ataxia Type 5 (EA5). It helps confirm the genetic cause of the disorder in symptomatic individuals.
TEST-1749 CAH (Congenital Adrenal Hyperplasia) Deletion & Duplication Detection Test This test identifies deletions and duplications within the CYP21A2 gene, which are common causes of 21-hydroxylase deficiency congenital adrenal hyperplasia.	Peripheral Whole Blood	7–10 Days	1,400.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CYP21A2 gene copy number variants (deletions/duplications)"] Parameters [] Preparation ["No specific fasting required", "Do not adjust or discontinue prescribed corticosteroid therapy without explicit guidance from your managing endocrinologist."] Indications ["Diagnosis of 21-hydroxylase deficiency CAH", "Carrier screening", "Prenatal diagnosis", "Confirmation of clinical suspicion"] Measurement technique Confirm with laboratory Codes LOINC: 94219-1 ICD-10: E25.0 Clinical summary This test identifies deletions and duplications within the CYP21A2 gene, which are common causes of 21-hydroxylase deficiency congenital adrenal hyperplasia.
TEST-3952 CALCRL Gene Genetic Test This genetic test evaluates the CALCRL gene for pathogenic variants associated with hereditary vascular system defects.	Whole Blood / Extracted DNA / FTA Card (One Drop)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CALCRL gene variants", "Pathogenic mutations"] Parameters [] Preparation ["No specific medication or supplement avoidance required", "Mandatory pre-test genetic counseling session required", "No fasting necessary"] Indications ["Personal or family history of unexplained vascular malformations", "Early-onset vascular events", "Known familial predisposition to vascular disorders", "Asymptomatic adult family members of a proband with a confirmed CALCRL pathogenic variant"] Measurement technique Confirm with laboratory Codes LOINC: 21665-7 ICD-10: Q27.8 Clinical summary This genetic test evaluates the CALCRL gene for pathogenic variants associated with hereditary vascular system defects.
TEST-4110 CALM1 Gene Catecholaminergic Polymorphic Ventricular Tachycardia Type 4 (CPVT4) Genetic Test This genetic test analyzes the CALM1 gene to identify variants associated with Catecholaminergic Polymorphic Ventricular Tachycardia Type 4 (CPVT4).	Peripheral Whole Blood (3–5 mL in EDTA tube) or Buccal Swab / FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CALM1 gene sequence", "Pathogenic variants in CALM1"] Parameters [] Preparation ["No fasting required", "No medication adjustment required"] Indications ["Suspected CPVT4", "Family history of CPVT4", "Risk stratification for sudden cardiac death"] Measurement technique Confirm with laboratory Codes LOINC: 81313-8 ICD-10: I47.2 Clinical summary This genetic test analyzes the CALM1 gene to identify variants associated with Catecholaminergic Polymorphic Ventricular Tachycardia Type 4 (CPVT4).
TEST-2138 CALR Exon 9 Mutation Analysis (NGS) Test This test detects somatic insertions and deletions within the CALR exon 9 region using Next-Generation Sequencing (NGS). It is used for the diagnosis and risk stratification of Phi...	Whole Blood (Peripheral)	10–15 business days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Somatic insertions/deletions in CALR exon 9", "Variant Allele Frequency (VAF)"] Parameters [] Preparation ["No fasting required", "Stay well-hydrated", "Provide clinical history, medication list, and previous reports"] Indications ["Diagnosis of Philadelphia-negative MPNs (Essential Thrombocythemia, Primary Myelofibrosis)", "Prognostic stratification in MPNs", "Detection of CALR mutations when JAK2 and MPL are negative"] Measurement technique Confirm with laboratory Codes LOINC: 94477-5 ICD-10: D47.3, D47.4 Clinical summary This test detects somatic insertions and deletions within the CALR exon 9 region using Next-Generation Sequencing (NGS). It is used for the diagnosis and risk stratification of Philadelphia-negative myeloproliferative neoplasms (MPNs).
TEST-1744 CALR Mutation Analysis (Exon 9) Test This test detects mutations (insertions/deletions) in exon 9 of the CALR gene using Sanger sequencing.	Peripheral Whole Blood (EDTA)	7–8 working days	1,200.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CALR gene exon 9 insertions/deletions"] Parameters [] Preparation [] Indications ["Diagnosis of essential thrombocythemia", "Diagnosis of primary myelofibrosis", "Risk stratification in myeloproliferative neoplasms"] Measurement technique Confirm with laboratory Codes LOINC: 94758-5 ICD-10: D47.3, D47.1 Clinical summary This test detects mutations (insertions/deletions) in exon 9 of the CALR gene using Sanger sequencing.

Category overview

Genetics: overview

Understanding your unique biological blueprint offers a profound sense of clarity and empowers proactive health planning for you and your family. At DNA Labs UAE, our specialized Genetics division employs state-of-the-art molecular technologies to provide deep insights into hereditary markers and cellular mutations. This comprehensive genetics testing in the UAE equips your healthcare provider with the precise data needed to tailor your medical guidance effectively. Recognized among top diagnostic labs in Dubai and the UAE, we prioritize your peace of mind through strict confidentiality protocols and exceptionally fast, accurate reporting. Take the next step in your health journey. View our genetics diagnostic services, book a private home collection, or consult our specialized team today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Genetics tests in Dubai & UAE

Genetics test prices

Genetics: overview

Use the test details as a conversation starter

Related Genetics categories